Halozyme Therapeutics
HALO
#2402
Rank
S$9.65 B
Marketcap
S$82.07
Share price
0.60%
Change (1 day)
27.57%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$2.22 Billion

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are S$2.22 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$2.31 B6.05%
2023-12-31S$2.17 B-2.8%
2022-12-31S$2.24 B82.67%
2021-12-31S$1.22 B116.23%
2020-12-31S$0.56 B-11.23%
2019-12-31S$0.63 B144.5%
2018-12-31S$0.26 B-37.27%
2017-12-31S$0.41 B-2.06%
2016-12-31S$0.42 B116.74%
2015-12-31S$0.19 B19.22%
2014-12-31S$0.16 B6.72%
2013-12-31S$0.15 B46.93%
2012-12-31S$0.10 B47.82%
2011-12-31S$71.04 M-22.31%
2010-12-31S$91.44 M-7.27%
2009-12-31S$98.61 M12.71%
2008-12-31S$87.49 M33.07%
2007-12-31S$65.75 M86.35%
2006-12-31S$35.28 M820.02%
2005-12-31S$3.83 M48.84%
2004-12-31S$2.57 M454.63%
2003-12-31S$0.46 M-56.12%
2002-12-31S$1.05 M17287.99%
2001-12-31S$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
MannKind Corp
MNKD
S$0.69 B-68.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$118.03 B 5,203.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$17.95 B 706.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$149.85 B 6,633.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$85.56 B 3,744.78%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
S$147.13 B 6,511.41%๐Ÿ‡บ๐Ÿ‡ธ USA